We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA

Delisted

LUXA was delisted on the 28th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

90.13% less ownership

Funds ownership: 90.13% → 0% (-90%)

100% less funds holding

Funds holding: 72 → 0 (-72)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $311M → $0 (-$311M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 72

Holders
–
Holders Change
-72
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
72
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
-$30.1M
2
SC
Sculptor Capital
New York
-$20.2M
3
WAM
Weiss Asset Management
Massachusetts
-$18.1M
4
WH
Wolfswood Holdings
New York
-$14.4M
5
Marshall Wace
Marshall Wace
United Kingdom
-$13.8M

LUXA Hedge Fund Activity: Q4 2022 in Review

0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q4 2022, worth a combined $0 — down 100% from $311M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of LUXA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $30.1M sold.

  • 0 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $0 of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 72 closed out, a net change of -72 holders.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q4 2022 was Empyrean Capital Partners, an estimated $30.1M sold.

Based on aggregated 13F filings for Q4 2022.